fentanyl iontophoretic transdermal procedure and butabarbital both of those enhance sedation. Stay away from or Use Alternate Drug. Restrict use to clients for whom choice treatment method solutions are inadequate
Medicine.com Mobile Apps The easiest way to lookup drug details, discover pills, Test interactions and set up your personal personal medication information. Obtainable for Android and iOS units.
butabarbital will lower the extent or impact of ziprasidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown.
butabarbital will lower the extent or outcome of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
butabarbital will lower the level or influence of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
buprenorphine subdermal implant and butabarbital both of those enhance sedation. Stay clear of or Use Alternate Drug. Restrict use to sufferers for whom option therapy options are insufficient
butabarbital will minimize the extent or impact of eletriptan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
butabarbital will reduce the level or outcome of propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.
butabarbital will reduce the extent or effect of vincristine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Not known.
butabarbital will minimize the level or influence of cilostazol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
butabarbital will decrease the level or influence of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
fentanyl intranasal and butabarbital both of those increase sedation. Stay clear of or Use Alternate Drug. Restrict use to clients for whom choice treatment choices are inadequate
butabarbital increases toxicity of buprenorphine, long-acting injection by pharmacodynamic synergism. Modify Therapy/Watch Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants boosts possibility of adverse reactions including overdose, respiratory depression, and Loss of life. Cessation of benzodiazepines or other CNS depressants is desired usually.
Use caution in repeated administration to sufferers with anemia, or with cardiovascular, pulmonary, read more or renal condition porphyria